verapamil and 4'-(9-acridinylamino)methanesulfon-o-anisidide

verapamil has been researched along with 4'-(9-acridinylamino)methanesulfon-o-anisidide in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (50.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bacsó, Z; Cianfriglia, M; Fenyvesi, F; Goda, K; Kappelmayer, J; Lustyik, G; Nagy, H; Szabó, G; Szilasi, M	1
Darkin, S; Ralph, RK	1

Other Studies

2 other study(ies) available for verapamil and 4'-(9-acridinylamino)methanesulfon-o-anisidide

Article	Year
Distinct groups of multidrug resistance modulating agents are distinguished by competition of P-glycoprotein-specific antibodies. Biochemical and biophysical research communications, 2004, Mar-19, Volume: 315, Issue:4 Topics: Adenosine Triphosphatases; Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding, Competitive; Calcium Channel Blockers; Cyclosporine; Detergents; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Fluoresceins; Humans; Ivermectin; Mice; NIH 3T3 Cells; Substrate Specificity	2004
Potentiation of 4'-(9-acridinylamino)methanesulphon-m-anisidine) action by verapamil. Cancer letters, 1986, Volume: 30, Issue:1 Topics: Aminoacridines; Amsacrine; Animals; Cell Line; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Synergism; Mast-Cell Sarcoma; Mice; Structure-Activity Relationship; Verapamil	1986

Article

Year

Distinct groups of multidrug resistance modulating agents are distinguished by competition of P-glycoprotein-specific antibodies.

Biochemical and biophysical research communications, 2004, Mar-19, Volume: 315, Issue:4

Topics: Adenosine Triphosphatases; Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding, Competitive; Calcium Channel Blockers; Cyclosporine; Detergents; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Fluoresceins; Humans; Ivermectin; Mice; NIH 3T3 Cells; Substrate Specificity

2004

Potentiation of 4'-(9-acridinylamino)methanesulphon-m-anisidine) action by verapamil.

Cancer letters, 1986, Volume: 30, Issue:1

Topics: Aminoacridines; Amsacrine; Animals; Cell Line; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Synergism; Mast-Cell Sarcoma; Mice; Structure-Activity Relationship; Verapamil

1986